GlassScriptPhysician profile
Amanda Lemp
NPI 1952980419
$1,052.85
in general payments reported to CMS, 2019-2025
16 companies · $617 in 2025
The $617 reported for 2025 was more than what 77% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $69.69 · 2022: $94.72 · 2023: $52.97 · 2024: $219 · 2025: $617.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $888.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $888.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $196.45 | 2021-2025 | Breztri, Farxiga, Airsupra |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $180.05 | 2022-2025 | Caplyta |
| Abbvie INC. | $126.67 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $106.54 | 2024-2025 | Abilify Asimtufii, Abilify Maintena, Rexulti |
| Novo Nordisk INC | $75.90 | 2024-2025 | Rybelsus, Ozempic |
| Boehringer Ingelheim Pharmaceuticals, INC. | $68.60 | 2021-2024 | Tradjenta, Jardiance, Cyltezo |
| Lilly USA, LLC | $59.14 | 2022-2025 | Mounjaro |
| Merck Sharp & Dohme LLC | $52.32 | 2021-2025 | Vaxneuvance, Gardasil 9, Enflonsia |
| Exact Sciences Corporation | $37.51 | 2025 | Cologuard Collection Kit |
| Glaxosmithkline, LLC. | $31.46 | 2024-2025 | Trelegy Ellipta, Arexvy |
| Neurocrine Biosciences, INC. | $22.17 | 2024 | Ingrezza |
| Eisai INC. | $21.63 | 2021 | |
| Organogenesis INC. | $20.69 | 2025 | Apligraf |
| Daiichi Sankyo INC. | $20.64 | 2023 | Injectafer |
| Lundbeck LLC | $18.73 | 2024 | Rexulti |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $14.35 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Lemp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.